70 million market cap for AGN back in 2023 for “encouraging pre clinical results” compared to NYR 15 million market cap which already has “significant” and “strong efficacy”. Results for NYR were significantly stronger in stroke and Walter reed for traumatic brain injury that starts in April put NYR on the path to a 100 million dollar market cap at a 80 cents target price short term. Interesting times ahead
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)